Immunostimulation to reduce recurrence after surgery for anal condyloma acuminata: a prospective randomized controlled trial

Colorectal Dis. 2010 Aug;12(8):799-803. doi: 10.1111/j.1463-1318.2009.01960.x. Epub 2009 Jun 22.

Abstract

Aim: Human papillomavirus is the most common cause of sexually transmitted disease. It is associated with immunosuppression and shows a marked tendency to recur. We investigated a natural immunostimulant aimed to reduce recurrence.

Method: A randomized controlled study was carried out including 261 patients allocated to surgical excision alone (control group; n = 122) and surgical excision plus postoperative immunostimulation for 30 days with a natural product (STET; study group; n = 139). Patients with HIV positivity were excluded. All patients gave fully informed consent.

Results: The patients were followed for 6 months after surgery. Recurrence occurred in 7.2% (10/139) in the study group and in 27.1% (33/122) in the control group (P < 0.0001). There were no significant differences in the sex, sexual orientation, number of lesions, time to diagnosis and treatment or localization of lesions in the two groups.

Conclusions: Immunostimulation using a natural product significantly reduced the incidence of recurrence of anal condylomata in patients undergoing surgical excision.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adjuvants, Immunologic / therapeutic use*
  • Adolescent
  • Adult
  • Andrographis
  • Anus Diseases / surgery*
  • Anus Diseases / therapy*
  • Anus Diseases / virology
  • Carica
  • Child
  • Citrus paradisi
  • Condylomata Acuminata / surgery*
  • Condylomata Acuminata / therapy*
  • Echinacea
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phytotherapy / methods
  • Plant Preparations / therapeutic use*
  • Prospective Studies
  • Secondary Prevention
  • Statistics, Nonparametric
  • Tabebuia
  • Uncaria
  • Young Adult

Substances

  • Adjuvants, Immunologic
  • Plant Preparations